ViaCell, Inc., a wholly owned subsidiary of PerkinElmer, is dedicated to enabling the widespread application of human cells as medicine. The Company markets ViaCord®, a product offering through which families can preserve their baby's umbilical cord blood at the time of birth for possible... more

Biomira is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Biomira's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes... more

TheraVitae is an international biotechnology company at the forefront of regenerative medicine with a mission to make the benefits of adult stem cell therapy accessible and affordable to the millions of people suffering from diseases once seen as incurable.

Opexa Therapeutics, Inc. (Opexa or Opexa Therapeutics) is a biopharmaceutical company developing autologous cellular therapies to treat several illnesses, including multiple sclerosis (MS), rheumatoid arthritis (RA), and diabetes. These therapies are based on the Company’s T-cell and... more

MaxCyte was founded in 1999 to commercialize flow electroporation technology exclusively from the CBR Institute for Biomedical Research. The technology was intended for clinical use, and the application that had been proposed when the technology was first acquired involved loading 1 liter... more

BrainStorm (OTC BB: BCLI) is a company that is developing stem cell technologies to provide treatments for currently incurable neurodegenerative diseases. The Company is focused on developing adult stem cells taken from the patient's own bone marrow to treat diseases such as Parkinson's... more

PharmaFrontiers' strategy is to develop and commercialize cell therapies to treat several major disease areas such as multiple sclerosis, rheumatoid arthritis, pancreatic and cardiac conditions. PharmaFrontiers has exclusive license from Baylor College of Medicine for individualized cell... more

Isolagen, Inc.(Isolagen) is an aesthetic and therapeutic development stage company focused on developing skin and tissue rejuvenation products. The Company's clinical development product candidates are designed to improve the appearance of skin injured by the effects of aging, sun... more

StemCells, Inc. is a biopharmaceutical company. The Company is engaged in the discovery and development of cell-based therapeutics to treat damage to, or degeneration of, major organ systems. The Company has product development programs for two cell types: the human neural stem cell and... more

BresaGen is a biotechnology company committed to the commercial development of protein and peptide therapeutics. Drawing on two decades of experience, the company has earned a reputation for excellence in the process development and manufacture of recombinant protein and peptide... more

Progenitor Cell Therapy is a commercial cell engineering company that provides for the collection, manufacture, storage and redistribution of human cells for therapeutic purposes through a nationwide network, operated in compliance with current Good Manufacturing Practices.

Cytori Therapeutics, Inc. develops, manufactures, and sells medical technologies to enable the practice of regenerative medicine. The Company’s commercial activities are focused on reconstructive surgery in Europe and Asia-Pacific, and stem and regenerative cell banking (cell... more

Xcyte Therapies, Inc. is a biotechnology company developing a new class of therapeutic products designed to enhance the body's natural immune responses to treat cancer, infectious diseases and other medical conditions associated with weakened immune systems. Xcyte derives its therapeutic... more

Miltenyi Biotec GmbH is a diversified biotechnology company focused on cell separation, molecular biology, GMP manufacturing and cellular therapies. By combining competencies in biologics and device technologies, Miltenyi Biotec is uniquely positioned to provide researchers and clinicians... more

Intercytex is a regenerative medicine company developing innovative products to restore skin and hair. Intercytex uses its fully integrated cell technology platform to develop living, human cell-based products that harness the innate ability of human cells to regenerate and repair the... more

Cyntellect, Inc. develops and commercializes proprietary products for high-throughput imaging and laser-based manipulation of living cells. Cyntellect combines expertise in high-speed imaging & computing, laser-based medicine, and automation to develop products that are used in... more

Cytomedix, Inc. is a biotechnology company that develops, sells, and licenses autologous cellular therapies (therapies using the patient’s own body products), including AutoloGel, a platelet rich plasma (PRP) gel cleared by the United States Food and Drug Administration (FDA) for use on a... more

Arteriocyte, a clinical stage biotechnology company located in Cleveland, Ohio and Hopkinton, Massachusetts, is developing proprietary, cellular-based therapeutics. The Company spun out of Case Western Reserve University in 2004 and is based upon research utilizing stem cells to stimulate... more

Novocell, Inc. is a stem cell engineering company dedicated to creating, delivering and commercializing cell and drug therapies to treat diabetes and other chronic diseases. Novocell uses its proprietary cell encapsulation technology and expertise in cell implantation to develop a... more

Innate Pharma SA is a France-based biopharmaceutical company that develops drugs targeting the innate immune system. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma SA primarily... more

TiGenix NV (Euronext: TIG) is a late-stage biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints.

Symphony Medical, Inc. develops novel biopolymer and cellular therapies for the treatment of cardiac conduction disorders.

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped under the modality of Biotherapy. Biotherapy is based on treatments that enhance the... more

CellExSys, Inc. was established in late 2000 as a subsidiary of Targeted Genetics Corporation, with a focus on commercializing a robust portfolio of cell therapy assets that are outside of Targeted Genetics' core focus. CellExSys' patient-specific technology platform has yielded promising... more

Morphogenesis is an emerging cell therapy company developing therapeutic products and devices for the fast-growing, multi-billion dollar cell therapy, tissue engineering and immunotherapy markets. The Company's initiatives can be broken down into three platforms or divisions; Cell... more

Stemnion, Inc. is a privately held, cutting-edge biomedical company engaged in the research and development of unique amnion-derived multipotent progenitor cells for use in cell- and cell-product-based therapies. The Company's focus is on regenerative medicine and cell transplantation... more

Sertoli Technologies Inc. is a cellular therapy company with platform technology for creating a local immunoprivileged site enabling the therapeutic transplantation of cells and cell-based gene therapy. Sertoli has a comprehensive patent portfolio covering the application of Sertoli... more

Providence, Rhode Island-based CytoTherapeutics is a leader in the development of cell-based therapeutics.

Sernova Corp. is a Canada-based Company, which is engaged in the research and development of treatment Type 1 human diabetes using transplanted devices containing porcine cells. During the fiscal year ended October 31, 2007 (fiscal 2007), the Company has no products in commercial... more

PanCel is an early stage cellular therapy company that has developed technology to genetically engineer pancreatic cell lines for the eventual cure of diabetes. PanCel's founding scientists are leaders in engineering human pancreatic cells with the potential to produce insulin. This... more

Incorporated in 2005 and headquartered in Hackensack, New Jersey, Amorcyte, Inc. is a development stage cellular therapies company focused on developing cell therapeutics for cardiovascular disease. Our lead product, AMR-001 is an autologous stem cell product for the treatment of... more

RenaMed Biologics, Inc. is the leading clinical stage company focused on the development of proprietary Bio-Replacement Therapies for critical disease states involving compromised kidney function. The company's lead product is intended to replace the biologic functions of the kidney that... more

Manufacturer of Lesther bandsaw machines for industrial uses specially steel structures.

Sangretech Asia Biomedical Corporation is dedicated to developing and commercializing novel therapies for cancer and other medical conditions. Our goal is to improve patients' lives by building a leading biomedical company focused on cellular therapies. The company was founded by Dr.... more